Vgi Partners LTD Zai Lab LTD Transaction History

Vgi Partners LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$30.21 - $48.1 $109,390 - $174,170	3,621 Added 8.21%	47,699 $1.59 Million
Q4 2022 Aug 15, 2023	SELL	$22.28 - $38.71 $466,142 - $809,890	-20,922 Reduced 32.19%	44,078 $1.35 Million
Q4 2022 Feb 14, 2023	SELL	$22.28 - $38.71 $466,142 - $809,890	-20,922 Reduced 32.19%	44,078 $1.35 Million
Q3 2022 Aug 15, 2023	BUY	$34.2 - $51.69 $2.22 Million - $3.36 Million	65,000 New	65,000 $2.22 Million
Q2 2022 Sep 09, 2022	BUY	$23.14 - $49.68 $1.5 Million - $3.23 Million	65,000 New	65,000 $2.25 Million

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.57B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Vgi Partners LTD, based on Form 13F filings with the SEC.

Stay updated on Vgi Partners LTD with notifications on news.